Natco Pharma receives EIR from USFDA for Kothur unit

20 Jul 2017 Evaluate

Natco Pharma has received successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug formulations facility at Kothur Unit, Telangana, India, during the period Jan 16th - 24th, 2017. This Kothur formulation facility predominantly caters to regulated international markets, including USA.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.



Natco Pharma Share Price

903.55 6.50 (0.72%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×